Maa: Armenia
Kieli: englanti
Lähde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
nifuratel, nystatine
Doppel Farmaceutici S.r.l.
G01AA51
nifuratel, nystatine
10g/100g+ 4000000IU/100g
cream vaginal
30g aluminium tube and dosing syringe applicator
Prescription
Registered
2020-12-31
_ _ SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF MEDICINAL PRODUCT Macmiror Complex 10 g / 4,000,000 I.U. vaginal cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 100 g of vaginal cream contains: Active substances: nifuratel 10 g and nystatin 4,000,000 I.U Excipients with known effect: methyl parahydroxybenzoate, propyl parahydroxybenzoate and propylene glycol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Vaginal cream. Description of the product: dark yellow fluid homogeneous cream. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Combination therapy of vulvovaginal conditions caused by drug-sensitive germs: bacteria, trichomonas, Candida fungi. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology 2.5 g of vaginal cream, once or twice a day, in the evening and/or the morning, for 8 days, according to the medical prescription. Method of administration The required dose of vaginal cream is applied using the dosing syringe. Instructions for using the dosing syringe 1. Screw the dosing syringe onto the tube of vaginal cream and squeeze the latter until the syringe contains the required amount of vaginal cream (according to the marks indicating grams of cream). 2. Unscrew the syringe from the tube and insert it into the vagina, pushing the plunger in. 3. Where required, remove the cannula from the plunger and screw it onto the opposite end of the syringe before inserting it into the vagina. One plastic applicator is enclosed in the packaging. After using the applicator it should be washed completely, and that way prepared for the next use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substances or to any one of the excipients listed in section 6.1. _ _ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Use of this medicinal product, particularly where prolonged, can lead to sensitisation phenomena. If any hypersensitivity reactions arise, administration of the medicinal product must be stopped. During the treatment sexual intercourse must be abstained from. This medicine contains the Lue koko asiakirja